Molecular profiling of colorectal cancer (CRC), the third most common cancer worldwide [1], has revealed that activation of WNT, MAPK, and PI3K signaling as well as alterations in TGF‐beta and DNA damage response pathways are common features of CRC [2, 3]. The gene discussed is TGFB1; the disease is colorectal carcinoma.